Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer
Clinical trial NCT03585998 · UNKNOWN
Trial details
- NCT number
- NCT03585998
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2021-06-19
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.